VRTX news · VRTX stock

Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?

Yahoo Finance · Aug 31, 2026 · Vertex Pharmaceuticals Inc (VRTX)

NBIX's Crenessity gains rapid traction in CAH, with sales soaring and low patient penetration leaving room for growth.

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.